Gastrointestinal cancer (anus, bile duct, colon, esophagus, gallbladder, liver, pancreas, rectum, small intestine), phase I clinical trials
Developing and performing clinical trials for novel anti-cancer therapies, particularly therapies for cancers of the upper GI tract (esophagus and stomach). I aim to incorporate pharmacogenomics into novel clinical trials in order to move towards customized cancer therapy.
- 1993: MD, University of Texas Southwestern Medical School, Dallas
- 2001: MHS, Duke University, Durham, N.C.
- 1993 - 1996: Intern and resident, internal medicine, Washington University, St. Louis
- 1997 - 2001: Fellow, hematology/oncology, Duke University, Durham, N.C.
- 1996, 2006: American Board of Internal Medicine, Internal Medicine
- 2000: American Board of Internal Medicine, Medical Oncology
Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.